Call for Abstract Open for ICARO-3

The International Atomic Energy Agency (IAEA) is organizing the third International Conference on Advances in Radiation Oncology (ICARO-3), following the successes of the first and second conferences (ICARO-1 and ICARO-2), which were held in 2009 and 2017. The advances in radiotherapy in the last years have been striking, although numerous challenges remain, including achieving access to high standard cancer care in many countries. New radiotherapy techniques have been implemented in the past decades, including three-dimensional conformal therapy, stereotactic radiotherapy, intensity modulated radiation therapy, image guided and stereotactic body radiation therapy, tomotherapy, new brachytherapy and unsealed-source techniques, and proton and heavy ion therapy. The increased use of these complex techniques, coupled with the need to treat more patients in less time, will continue to drive a reliance on high-end technologies and impose a financial burden on health care programmes. In addition, the development and implementation of quality assurance programmes for these new techniques pose major challenges in Member States.
The conference will give health care professionals an opportunity to review the current developments in clinical applications in the fields of radiation oncology, radiation biology and medical physics, with a view to addressing the challenges of appropriate cancer management in Member States.
It will also critically examine the pivotal role of emerging radiotherapy techniques in tackling the health challenges common to many Member States.
An appropriate number of accredited continuing medical education (CME) credits will be awarded to participants.

https://www.iaea.org/sites/default/files/20/04/cn288-announcement.pdf